- Home
- HNST vs ORIC Comparison
HNST vs ORIC Comparison
Compare HNST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- ORIC
- Stock Information
- Founded
- HNST 2012
- ORIC 2014
- Country
- HNST United States
- ORIC United States
- Employees
- HNST N/A
- ORIC N/A
- Industry
- HNST Catalog/Specialty Distribution
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- HNST Consumer Discretionary
- ORIC Health Care
- Exchange
- HNST Nasdaq
- ORIC Nasdaq
- Market Cap
- HNST 639.1M
- ORIC 633.7M
- IPO Year
- HNST 2021
- ORIC 2020
- Fundamental
- Price
- HNST $6.58
- ORIC $9.58
- Analyst Decision
- HNST Buy
- ORIC Strong Buy
- Analyst Count
- HNST 6
- ORIC 9
- Target Price
- HNST $6.71
- ORIC $18.75
- AVG Volume (30 Days)
- HNST 2.5M
- ORIC 597.6K
- Earning Date
- HNST 03-05-2025
- ORIC 03-10-2025
- Dividend Yield
- HNST N/A
- ORIC N/A
- EPS Growth
- HNST N/A
- ORIC N/A
- EPS
- HNST N/A
- ORIC N/A
- Revenue
- HNST $368,767,000.00
- ORIC N/A
- Revenue This Year
- HNST $11.05
- ORIC N/A
- Revenue Next Year
- HNST $5.78
- ORIC N/A
- P/E Ratio
- HNST N/A
- ORIC N/A
- Revenue Growth
- HNST 9.77
- ORIC N/A
- 52 Week Low
- HNST $2.40
- ORIC $6.33
- 52 Week High
- HNST $8.97
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- HNST 49.50
- ORIC 54.79
- Support Level
- HNST $5.63
- ORIC $7.86
- Resistance Level
- HNST $6.71
- ORIC $11.15
- Average True Range (ATR)
- HNST 0.33
- ORIC 0.72
- MACD
- HNST -0.04
- ORIC 0.23
- Stochastic Oscillator
- HNST 63.33
- ORIC 52.28
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.